Гемофлекс | Эффективное средство борьбы с кровотечением

An effective means for stopping external traumatic bleeding

topical hemostatic agent

It is a next-generation medical device designed to provide first aid and emergency care for the temporary stopping of external arterial, venous, and capillary bleeding.

Chitosan is the main active ingredient.

It is a polymer with hemostatic activity, antibacterial properties, biocompatibility, and the ability to biodegrade.

Why does Hemoflex save lives?

Advantages of the product

Relevance

Blood loss is one of the leading causes of death in man-made and natural disasters, accidents, and armed conflicts.

Therefore, one of the key issues in modern emergency medicine remains the problem of timely and effective prehospital bleeding control, especially in injuries to large veins and arteries, as well as the provision of reliable hemostasis during transport of the victim to a medical facility.

Relevance

Blood loss is one of the leading causes of death in technological and natural disasters, accidents, and armed conflicts.

Therefore, one of the key issues in modern emergency medicine remains the problem of timely and effective prehospital bleeding control, especially in injuries to large veins and arteries, as well as ensuring reliable hemostasis during transport of the victim to a medical facility.

Innovations

Original scientific research and development made it possible to introduce a competitive medical device for the temporary stopping of external bleeding into domestic production: Hemoflex.

Solutions

For first aid and emergency care to stop bleeding of varying severity, topical hemostatic agents are used both in Russia and abroad.

Medical devices for the temporary control of external bleeding based on the biopolymer N-acetyl-1,4- 𝛽 β-D-glucosamine, better known as chitosan, have become the most widely used.

Solution

Local hemostatic agents are used to provide first aid and emergency care to stop bleeding of varying intensity, both in Russia and abroad.

At the same time, the most widely used medical devices for the temporary control of external bleeding are based on the biopolymer N-acetyl-1,4-β-D-glucosamine, better known as chitosan.

SAFETY

Preclinical and clinical studies of Hemoflex® showed high hemostatic efficacy and better hemostasis stability compared with analogues.

The production technology has no analogues in Russia. We are pleased to offer a product that not only meets high quality standards, but also exceeds expectations, providing the highest level of safety and reliability in critical situations.